Selected research
Market Structure
Global Pharmaceutical Validation Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Pharmaceutical Validation Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Pharmaceutical Validation Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Pharmaceutical Validation Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pharmaceutical Validation Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Pharmaceutical Validation Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Pharmaceutical Validation Services include Arbor Group, ATS Global, Catalent, CRS Pharma Solutions, Eurofins Scientific, Körber Pharma, Merck Millipore, MTS (Meissner Technical Services) and Navitas pharma READY, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Pharmaceutical Validation Services market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Pharmaceutical Validation Services and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Pharmaceutical Validation Services revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Pharmaceutical Validation Services market size, projected growth trends, production technologies, key applications, and end-use industries.
Pharmaceutical Validation Services Segment by Company
Arbor Group
ATS Global
Catalent
CRS Pharma Solutions
Eurofins Scientific
Körber Pharma
Merck Millipore
MTS (Meissner Technical Services)
Navitas pharma READY
PharmOut
SGS
Sigma-Aldrich
SL Controls
Transcat
Pharmaceutical Validation Services Segment by Type
Pharmaceutical Cleaning Validation Services
Pharmaceutical Equipment Validation Services
Others
Pharmaceutical Validation Services Segment by Application
Pharmaceutical Companies
Biotechnological Companies
Academic and Research Institutes
Pharmaceutical Validation Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Validation Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Validation Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Validation Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Pharmaceutical Validation Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical Validation Services industry.
Chapter 3: Detailed analysis of Pharmaceutical Validation Services companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical Validation Servicesrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Pharmaceutical Cleaning Validation Services
- Pharmaceutical Equipment Validation Services
- Others
Applications
- Pharmaceutical Companies
- Biotechnological Companies
- Academic and Research Institutes
Companies covered
- Arbor Group
- ATS Global
- Catalent
- CRS Pharma Solutions
- Eurofins Scientific
- Körber Pharma
- Merck Millipore
- MTS (Meissner Technical Services)
- Navitas pharma READY
- PharmOut
- SGS
- Sigma-Aldrich
- SL Controls
- Transcat
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Pharmaceutical Validation Services Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Pharmaceutical Cleaning Validation Services
- 1.2.3 Pharmaceutical Equipment Validation Services
- 1.2.4 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Pharmaceutical Validation Services Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Pharmaceutical Companies
- 1.3.3 Biotechnological Companies
- 1.3.4 Academic and Research Institutes
- 1.4 Global Market Growth Prospects
- 1.5 Global Pharmaceutical Validation Services Growth Trends by Region
- 1.5.1 Global Pharmaceutical Validation Services Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Pharmaceutical Validation Services Market Size by Region (2021-2026)
- 1.5.3 Pharmaceutical Validation Services Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Pharmaceutical Validation Services Market Dynamics
- 2.1 Pharmaceutical Validation Services Industry Trends
- 2.2 Pharmaceutical Validation Services Industry Drivers
- 2.3 Pharmaceutical Validation Services Industry Opportunities and Challenges
- 2.4 Pharmaceutical Validation Services Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Pharmaceutical Validation Services Revenue by Company (2021-2026)
- 3.2 Global Pharmaceutical Validation Services Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Pharmaceutical Validation Services Key Company Head office and Area Served
- 3.4 Global Pharmaceutical Validation Services Company, Product Type & Application
- 3.5 Global Pharmaceutical Validation Services Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Pharmaceutical Validation Services Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Pharmaceutical Validation Services Players Market Share by Revenue in 2025
- 3.6.3 2025 Pharmaceutical Validation Services Tier 1, Tier 2, and Tier 3
4 Pharmaceutical Validation Services Market by Type
- 4.1 Global Pharmaceutical Validation Services Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Pharmaceutical Validation Services Market Size by Type (2021-2032)
- 4.3 Global Pharmaceutical Validation Services Market Size Share by Type (2021-2032)
5 Pharmaceutical Validation Services Market by Application
- 5.1 Global Pharmaceutical Validation Services Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Pharmaceutical Validation Services Market Size by Application (2021-2032)
- 5.3 Global Pharmaceutical Validation Services Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Arbor Group
- 6.1.1 Arbor Group Company Information
- 6.1.2 Arbor Group Business Overview
- 6.1.3 Arbor Group Pharmaceutical Validation Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Arbor Group Pharmaceutical Validation Services Product Portfolio
- 6.1.5 Arbor Group Recent Developments
- 6.2 ATS Global
- 6.2.1 ATS Global Company Information
- 6.2.2 ATS Global Business Overview
- 6.2.3 ATS Global Pharmaceutical Validation Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 ATS Global Pharmaceutical Validation Services Product Portfolio
- 6.2.5 ATS Global Recent Developments
- 6.3 Catalent
- 6.3.1 Catalent Company Information
- 6.3.2 Catalent Business Overview
- 6.3.3 Catalent Pharmaceutical Validation Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Catalent Pharmaceutical Validation Services Product Portfolio
- 6.3.5 Catalent Recent Developments
- 6.4 CRS Pharma Solutions
- 6.4.1 CRS Pharma Solutions Company Information
- 6.4.2 CRS Pharma Solutions Business Overview
- 6.4.3 CRS Pharma Solutions Pharmaceutical Validation Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 CRS Pharma Solutions Pharmaceutical Validation Services Product Portfolio
- 6.4.5 CRS Pharma Solutions Recent Developments
- 6.5 Eurofins Scientific
- 6.5.1 Eurofins Scientific Company Information
- 6.5.2 Eurofins Scientific Business Overview
- 6.5.3 Eurofins Scientific Pharmaceutical Validation Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Eurofins Scientific Pharmaceutical Validation Services Product Portfolio
- 6.5.5 Eurofins Scientific Recent Developments
- 6.6 Körber Pharma
- 6.6.1 Körber Pharma Company Information
- 6.6.2 Körber Pharma Business Overview
- 6.6.3 Körber Pharma Pharmaceutical Validation Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Körber Pharma Pharmaceutical Validation Services Product Portfolio
- 6.6.5 Körber Pharma Recent Developments
- 6.7 Merck Millipore
- 6.7.1 Merck Millipore Company Information
- 6.7.2 Merck Millipore Business Overview
- 6.7.3 Merck Millipore Pharmaceutical Validation Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Merck Millipore Pharmaceutical Validation Services Product Portfolio
- 6.7.5 Merck Millipore Recent Developments
- 6.8 MTS (Meissner Technical Services)
- 6.8.1 MTS (Meissner Technical Services) Company Information
- 6.8.2 MTS (Meissner Technical Services) Business Overview
- 6.8.3 MTS (Meissner Technical Services) Pharmaceutical Validation Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 MTS (Meissner Technical Services) Pharmaceutical Validation Services Product Portfolio
- 6.8.5 MTS (Meissner Technical Services) Recent Developments
- 6.9 Navitas pharma READY
- 6.9.1 Navitas pharma READY Company Information
- 6.9.2 Navitas pharma READY Business Overview
- 6.9.3 Navitas pharma READY Pharmaceutical Validation Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Navitas pharma READY Pharmaceutical Validation Services Product Portfolio
- 6.9.5 Navitas pharma READY Recent Developments
- 6.10 PharmOut
- 6.10.1 PharmOut Company Information
- 6.10.2 PharmOut Business Overview
- 6.10.3 PharmOut Pharmaceutical Validation Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 PharmOut Pharmaceutical Validation Services Product Portfolio
- 6.10.5 PharmOut Recent Developments
- 6.11 SGS
- 6.11.1 SGS Company Information
- 6.11.2 SGS Business Overview
- 6.11.3 SGS Pharmaceutical Validation Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 SGS Pharmaceutical Validation Services Product Portfolio
- 6.11.5 SGS Recent Developments
- 6.12 Sigma-Aldrich
- 6.12.1 Sigma-Aldrich Company Information
- 6.12.2 Sigma-Aldrich Business Overview
- 6.12.3 Sigma-Aldrich Pharmaceutical Validation Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Sigma-Aldrich Pharmaceutical Validation Services Product Portfolio
- 6.12.5 Sigma-Aldrich Recent Developments
- 6.13 SL Controls
- 6.13.1 SL Controls Company Information
- 6.13.2 SL Controls Business Overview
- 6.13.3 SL Controls Pharmaceutical Validation Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 SL Controls Pharmaceutical Validation Services Product Portfolio
- 6.13.5 SL Controls Recent Developments
- 6.14 Transcat
- 6.14.1 Transcat Company Information
- 6.14.2 Transcat Business Overview
- 6.14.3 Transcat Pharmaceutical Validation Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Transcat Pharmaceutical Validation Services Product Portfolio
- 6.14.5 Transcat Recent Developments
7 North America
- 7.1 North America Pharmaceutical Validation Services Market Size (2021-2032)
- 7.2 North America Pharmaceutical Validation Services Market Size by Type
- 7.2.1 North America Pharmaceutical Validation Services Market Size by Type (2021-2026)
- 7.2.2 North America Pharmaceutical Validation Services Market Size by Type (2027-2032)
- 7.2.3 North America Pharmaceutical Validation Services Market Share by Type (2021-2032)
- 7.3 North America Pharmaceutical Validation Services Market Size by Application
- 7.3.1 North America Pharmaceutical Validation Services Market Size by Application (2021-2026)
- 7.3.2 North America Pharmaceutical Validation Services Market Size by Application (2027-2032)
- 7.3.3 North America Pharmaceutical Validation Services Market Share by Application (2021-2032)
- 7.4 North America Pharmaceutical Validation Services Market Size by Country
- 7.4.1 North America Pharmaceutical Validation Services Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Pharmaceutical Validation Services Market Size by Country (2021-2026)
- 7.4.3 North America Pharmaceutical Validation Services Market Size by Country (2027-2032)
- 7.4.4 North America Pharmaceutical Validation Services Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Pharmaceutical Validation Services Market Size (2021-2032)
- 8.2 Europe Pharmaceutical Validation Services Market Size by Type
- 8.2.1 Europe Pharmaceutical Validation Services Market Size by Type (2021-2026)
- 8.2.2 Europe Pharmaceutical Validation Services Market Size by Type (2027-2032)
- 8.2.3 Europe Pharmaceutical Validation Services Market Share by Type (2021-2032)
- 8.3 Europe Pharmaceutical Validation Services Market Size by Application
- 8.3.1 Europe Pharmaceutical Validation Services Market Size by Application (2021-2026)
- 8.3.2 Europe Pharmaceutical Validation Services Market Size by Application (2027-2032)
- 8.3.3 Europe Pharmaceutical Validation Services Market Share by Application (2021-2032)
- 8.4 Europe Pharmaceutical Validation Services Market Size by Country
- 8.4.1 Europe Pharmaceutical Validation Services Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Pharmaceutical Validation Services Market Size by Country (2021-2026)
- 8.4.3 Europe Pharmaceutical Validation Services Market Size by Country (2027-2032)
- 8.4.4 Europe Pharmaceutical Validation Services Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Pharmaceutical Validation Services Market Size (2021-2032)
- 9.2 China Pharmaceutical Validation Services Market Size by Type
- 9.2.1 China Pharmaceutical Validation Services Market Size by Type (2021-2026)
- 9.2.2 China Pharmaceutical Validation Services Market Size by Type (2027-2032)
- 9.2.3 China Pharmaceutical Validation Services Market Share by Type (2021-2032)
- 9.3 China Pharmaceutical Validation Services Market Size by Application
- 9.3.1 China Pharmaceutical Validation Services Market Size by Application (2021-2026)
- 9.3.2 China Pharmaceutical Validation Services Market Size by Application (2027-2032)
- 9.3.3 China Pharmaceutical Validation Services Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Pharmaceutical Validation Services Market Size (2021-2032)
- 10.2 Asia Pharmaceutical Validation Services Market Size by Type
- 10.2.1 Asia Pharmaceutical Validation Services Market Size by Type (2021-2026)
- 10.2.2 Asia Pharmaceutical Validation Services Market Size by Type (2027-2032)
- 10.2.3 Asia Pharmaceutical Validation Services Market Share by Type (2021-2032)
- 10.3 Asia Pharmaceutical Validation Services Market Size by Application
- 10.3.1 Asia Pharmaceutical Validation Services Market Size by Application (2021-2026)
- 10.3.2 Asia Pharmaceutical Validation Services Market Size by Application (2027-2032)
- 10.3.3 Asia Pharmaceutical Validation Services Market Share by Application (2021-2032)
- 10.4 Asia Pharmaceutical Validation Services Market Size by Country
- 10.4.1 Asia Pharmaceutical Validation Services Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Pharmaceutical Validation Services Market Size by Country (2021-2026)
- 10.4.3 Asia Pharmaceutical Validation Services Market Size by Country (2027-2032)
- 10.4.4 Asia Pharmaceutical Validation Services Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Pharmaceutical Validation Services Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Pharmaceutical Validation Services Market Size by Type
- 11.2.1 South America, Middle East & Africa Pharmaceutical Validation Services Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Pharmaceutical Validation Services Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Pharmaceutical Validation Services Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Pharmaceutical Validation Services Market Size by Application
- 11.3.1 South America, Middle East & Africa Pharmaceutical Validation Services Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Pharmaceutical Validation Services Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Pharmaceutical Validation Services Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Pharmaceutical Validation Services Market Size by Country
- 11.4.1 South America, Middle East & Africa Pharmaceutical Validation Services Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Pharmaceutical Validation Services Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Pharmaceutical Validation Services Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Pharmaceutical Validation Services Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst